SV Health Investors — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Biotech company that reached IPO
BiotechCambridge
KEVIN LEE(Executive Officer, Director)FELIX J. BAKER(Director)RICHARD N. KENDER(Director)GREGORY WINTER(Director)STEPHEN SANDS(Director)NIGEL CROCKETT(Executive Officer)
SpectraWave develops imaging and physiology technologies for coronary care, combining deep optical coherence tomography, near-infrared spectroscopy, and wire-free FFR measurements on a single platform to support percutaneous coronary intervention planning in catheterization laboratories.
AI & Machine LearningHealthtechMedical DevicesBedford, US
Eman Namati(Executive Officer, Director)Eric Swanson(Director)Martin Seifert(Executive Officer, Director)Steven Hochberg(Director)Guillermo Tearney(Director)
Board seatPaul LaViolette· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.